Veltri R W, Wainwright W H, Sprinkle P M
J Natl Cancer Inst. 1976 Aug;57(2):245-53. doi: 10.1093/jnci/57.2.245.
We extracted the Epstein-Barr soluble antigen (EBSA) from the P3HR-1 human lymphoid cell line, which carries the Epstein-Barr virus (EBV), after P3HR-1 cells were activated with 5-iodo-2'-deoxyuridine. EBSA was identified as the early antigen (EA) complex by immunodiffusion and blocking immunofluorescence tests with high-titered human antiserum to EA. The identity of the EA complex was confirmed with antiserum to EA prepared in rabbits and adsorbed to assure its immunologic specificity. The EA was partially purified on Sephadex G-200. Further characterization by immunoelectrophoresis showed that the EBSA moved rapidly toward the anode. This indicated a highly negative charge. EBSA appeared to be distinct from the previously described complement-fixing S-antigen. It was demonstrable only in EA-producer lymphoid cell lines and reacted specifically with human antiserum to EA, whereas the S-antigen was found in all EBV-carrying lymphoid cell lines and reacted with all EBV antibody-positive human antisera.
在用5-碘-2'-脱氧尿苷激活P3HR-1细胞后,我们从携带爱泼斯坦-巴尔病毒(EBV)的P3HR-1人淋巴母细胞系中提取了爱泼斯坦-巴尔可溶性抗原(EBSA)。通过免疫扩散以及用高效价的人抗EA血清进行阻断免疫荧光试验,EBSA被鉴定为早期抗原(EA)复合物。用兔制备的抗EA血清并经吸附以确保其免疫特异性,从而证实了EA复合物的一致性。EA在葡聚糖凝胶G-200上进行了部分纯化。免疫电泳进一步表征显示EBSA快速向阳极移动。这表明其带有高度负电荷。EBSA似乎与先前描述的补体结合S抗原不同。它仅在产生EA的淋巴母细胞系中可检测到,并与人抗EA血清发生特异性反应,而S抗原在所有携带EBV的淋巴母细胞系中均有发现,并与所有EBV抗体阳性的人抗血清发生反应。